- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
The Scabies Drug market is a subset of the Infectious Diseases Drugs market. It is composed of pharmaceuticals used to treat scabies, a contagious skin condition caused by the mite Sarcoptes scabiei. Treatment typically involves the use of topical creams or lotions, which are applied to the affected area of skin. These drugs are designed to kill the mites and their eggs, as well as reduce inflammation and itching.
The Scabies Drug market is highly competitive, with a range of products available from both generic and branded manufacturers. These products are typically sold over-the-counter, as well as through prescription.
Some companies in the Scabies Drug market include GlaxoSmithKline, Bayer, Merck, Novartis, and Perrigo. Show Less Read more